Racemates designation

Contents Introduction. - Structure Determination Amino Acid Analysis. Sequence Determination. Secondary and Tertiary Stmcture. - Peptide Synthesis Formation of the Peptide Bond. Protection of Functional Groups. Undesired Reactions during Synthesis. Racemization. Design of Schemes for Peptide Synthesis. Solid Phase Peptide Synthesis. - Methods of Facilitation. Analysis and Characterization of Synthetic Peptides. -Subject Index. 

Thus, each stereochemical stnicttirc can be described and recognised with this rotational list if the structure is designated, c.g., in the STEREO block of the SMD format. The compact and extensible representation of the rotational list can include additional information, such as the name specification of the geometiy or whether the configuration is absohtte, relative, or racemic (Eigitre 2-73). 

Optically Inactive Chiral Compounds. Although chirality is a necessary prerequisite for optical activity, chiral compounds are not necessarily optically active. With an equal mixture of two enantiomers, no net optical rotation is observed. Such a mixture of enantiomers is said to be racemic and is designated as ( ) and not as dl. Racemic mixtures usually have melting points higher than the melting point of either pure enantiomer. 

When ofloxacin was first introduced it was made available as the racemate. Later the optical isomers were prepared and it was found that the (3)-enantiomer, DR 3355 (6b), was substantially more active (8—128-fold) than the (R)-isomer against a broad range of bacteria (47—50). This chiral preference is not unique to ofloxacin and has been demonstrated in other quinolones as well (51,52). This significant finding has already had an impact on the design of new quinolone antibacterials still in development (53). 

Chemical Designations - Synonyms 2-Hydroxypropanoic acid alpha-Hydroxypropionic acid Milk acid Racemic acid Chemical Formula CHjCHOHCOOH-HjO. 

Another possibility of constructing a chiral membrane system is to prepare a solution of the chiral selector which is retained between two porous membranes, acting as an enantioselective liquid carrier for the transport of one of the enantiomers from the feed solution of the racemate to the receiving side (Fig. 1-5). This system is often referred to as membrane-assisted separation. The selector should not be soluble in the solvent used for the elution of the enantiomers, whose transport is driven by a gradient in concentration or pH between the feed and receiving phases. As a drawback common to all these systems, it should be mentioned that the transport of one enantiomer usually decreases when the enantiomer ratio in the permeate diminishes. Nevertheless, this can be overcome by designing a system where two opposite selectors are used to transport the two enantiomers of a racemic solution simultaneously, as it was already applied in W-tube experiments [171]. 

In order to illustrate an example of process design for the manufacture of enantiopure drug substances on an industrial SMB system, consider manufacturing 10 ton/ year of an enantiopure drug. The racemic drug by definition is a 50 50 mixture of each enantiomer (products A and B). The goal is to process enantiopure drug substances in order to obtain 99 % purity for both the extract and the raffinate. 

In order to illustrate the critical process parameters of SMB process validation, we will consider the separation of the racemic drug as described in Process design. The study represents the effect of the influence of feed concentration, number of plates and retention factor on the second eluting enantiomer. The simulation of the process for different values of feed concentration is performed and the variations of the extract and raffinate purities are shown in Fig. 10.10. 

Another example of enzyme- and acid-catalyzed DKR has been reported by Bornscheuer [45]. Acyloins were racemized by using an acidic resin through the formation of enol intermediates. The enzymatic resolution was catalyzed by CALB. Since deactivation of this enzyme occurred in the presence of the acidic resin, they designed a simple reactor setup with two glass vials cormected via a pump to achieve a spatial separation between the acidic resin and the enzyme (Figure 4.20). 

In an effort directed at developing a racemization catalyst which works uniformly for all the substrates at room temperature, we designed and synthesized a novel aminocyclopentadienyl ruthenium chloride complex 5. The DKR of aromatic as well as aliphatic alcohols could be conducted at room temperature. In case of aromatic alcohols, the substituent effects were found insignificant in the DKR however, aromatic alcohols have comparatively faster conversion rates than their ahphatic counterparts. This is the first ever report of a catalyst... 

A summary of addition reactions of alkenes with 1-methylcyclopentene as the organic substrate. A bond designated means that the stereochemistry of the group is unspecified. For brevity the structure of only one enantiomer of the product is shown, even though racemic mixtures would be produced in all instances in which the product is chiral. 

---